HUMANA INC current report, Q1 FY2026

Business Context and Reporting Period

Company: Humana Inc.
Filing Type: Form 8-K (Current Report)
Reporting Period: March 5, 2026 (Event Date) to March 9, 2026 (Filing Date)
Context: The Company entered into a material definitive agreement to issue and sell $1.0 billion in aggregate principal amount of 6.625% Fixed-to-Fixed Rate Junior Subordinated Notes due 2056.

Key Financial Metrics

Metric Value
Aggregate Principal Amount $1.0 billion
Public Offering Price 100.000% of principal
Estimated Net Proceeds Approximately $986 million
Initial Interest Rate 6.625% per annum
Maturity Date September 15, 2056
Interest Payment Dates March 15 and September 15 (commencing September 15, 2026)

Note: This filing does not provide data on revenue, profit, cash flow, operating margins, or existing debt levels outside of the new issuance.

Material Changes and Transaction Details

  • Debt Issuance: Humana completed a public offering of $1.0 billion in unsecured junior subordinated notes.
  • Underwriters: Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Truist Securities, Inc., and Wells Fargo Securities, LLC.
  • Use of Proceeds: Net proceeds are intended for general corporate purposes, which may include repaying existing indebtedness, including borrowings under the Company's commercial paper program.
  • Interest Rate Reset: The rate is fixed at 6.625% until September 15, 2031. Thereafter, it resets every five years based on the Five-year U.S. Treasury Rate plus 2.891%, with a floor of 6.625%.
  • Deferral Option: The Company may defer interest payments for up to 10 consecutive years if no event of default has occurred.

Outlook, Risks, and Contingencies

  • Subordination Risk: The notes are unsecured and subordinate to all Senior Indebtedness. They are effectively junior to future secured indebtedness and structurally subordinated to liabilities of subsidiaries.
  • Interest Rate Risk: While the initial rate is fixed, future rates are variable and tied to U.S. Treasury rates, subject to a floor.
  • Liquidity Impact: The transaction increases liquidity by approximately $986 million in net proceeds, potentially reducing reliance on commercial paper.
  • Management Commentary: The filing incorporates press releases regarding pricing and closing but does not contain additional forward-looking guidance or commentary within the text provided.

Investor Verification Checklist

  • Verify the final net proceeds received after deducting underwriting discounts and offering expenses.
  • Confirm the specific allocation of proceeds toward the repayment of commercial paper or other existing debt.
  • Review the "Senior Indebtedness" definition in the First Supplemental Indenture to understand the full scope of senior claims.
  • Monitor the Company's ability to service the new debt, particularly given the option to defer interest payments.
  • Check subsequent filings for any changes in the Company's credit ratings following this issuance.